Baudax Bio, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • R&D
    • Product Portfolio
    • ANJESO® (meloxicam) injection
    • NMB & Reversal Agent
    • Investigator Sponsored Research
  • Therapeutic Areas
    • Post-Operative Pain
    • Anesthesia
  • News & Investors
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Governance
    • Stock Info
    • Financial & Filings
  • Contact
  • Careers
×

Please see full Prescribing Information for ANJESO, including  Important Safety Information and Boxed Warning, at www.anjeso.com.

Press Releases

News & Investors

News & Investors

  • Overview
  • Press Releases
  • Events
  • Presentations
  • Governance
    • Governance Documents
    • Board of Directors
    • Board Committees
  • Stock Info
    • Form 8937
  • Financial & Filings
    • Overview
    • All SEC Filings

Leading Independent Advisory Firm Institutional Shareholder Services, Inc. Recommends Baudax Bio Shareholders Vote “For” the Proposed Additional Authorized Shares at Upcoming Special Meeting of Shareholders

Jun 30, 2021 7:00am EDT

Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock

Jun 18, 2021 4:05pm EDT

Baudax Bio to Participate in the JMP Securities Life Sciences Conference

Jun 10, 2021 7:00am EDT

Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market

Jun 08, 2021 7:00am EDT

Baudax Bio Announces $11.9 Million Registered Direct Offering

May 31, 2021 10:56pm EDT

Baudax Bio Announces the Cancellation of Adjourned Portion of Annual Shareholder Meeting

May 28, 2021 4:05pm EDT

Baudax Bio to Present at the 2021 Jefferies Virtual Healthcare Conference

May 27, 2021 7:00am EDT

Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management

May 17, 2021 7:00am EDT

Leading Independent Advisory Firm Institutional Shareholder Services, Inc. Recommends Baudax Bio Shareholders Vote "For" the Proposed Additional Authorized Shares

May 13, 2021 7:00am EDT

Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders Vote "For" The Additional Authorized Shares

May 12, 2021 9:02am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    Next
    • Email Alerts
    • Tear Sheet
    • RSS News Feed
    © 2022 Baudax Bio, Inc. All Rights Reserved. ANJESO is a registered trademark of Baudax Bio, Inc.
    Privacy Policy Terms of Use Disclaimer Sitemap